Artificial universal blood type
Pro Research Analysisby 
Searched over 200M research papers
Universal Blood Type: Enzymatic Conversion and Antigen Masking
Enzymatic Conversion of Blood Types to Universal O
A major focus in creating universal blood is the enzymatic conversion of A, B, and AB red blood cells (RBCs) into O-type RBCs, which can be transfused into any patient. This process involves removing specific sugar antigens from the surface of RBCs. For type B blood, researchers have identified and engineered highly efficient α-1,3-galactosidases, such as PpaGal from Pedobacter panaciterrae, which can convert B antigens to the H antigen found in O-type blood, making the process more practical for clinical use 23. Similarly, for type A blood, pairs of enzymes—N-acetylgalactosamine deacetylase and galactosaminidase—have been discovered and optimized to efficiently remove the A antigen, achieving over 99% conversion in minutes under standard conditions 346. These advances significantly improve the feasibility of producing universal donor blood from existing supplies of A and B blood types.
Bacterial Enzymes and the Human Microbiome
Recent research has shown that bacterial enzymes, particularly those from gut bacteria like Akkermansia muciniphila, are effective at removing the sugar molecules that define A and B blood types. These enzymes are naturally adapted to degrade similar sugars in the human gut, making them especially efficient for blood group conversion 56. The use of such enzymes could help address shortages of O-type blood, which is often the first to run out during emergencies 15.
Antigen Masking and Cell Surface Engineering
Beyond enzymatic conversion, another promising approach is antigen masking. This involves chemically shielding the antigens on the surface of RBCs, such as the RhD antigen, to prevent immune recognition. A surface-anchored framework has been developed that effectively hides RhD antigens, creating "stealth" RBCs that can be used universally without triggering immune reactions. This method has shown success in animal models and offers a new direction for universal blood transfusion 19.
Gene Editing for Universal Blood
Gene editing technologies, such as CRISPR/Cas9, are also being explored to create universal blood. By editing the ABO gene in human-induced pluripotent stem cells (hiPSCs), researchers have converted blood type A cells to type O, even in rare blood types like Rhnull. This approach could enable the production of universal RBCs from rare donors, expanding the availability of compatible blood for patients with uncommon blood types .
Genotyping and Precision Matching
While universal blood is a key goal, advances in genotyping platforms are also improving blood transfusion safety. High-throughput DNA-based tests can identify a wide range of blood group antigens, allowing for more precise matching between donors and recipients. This reduces the risk of immune sensitization and increases the pool of compatible donors, especially for patients with multiple alloantibodies .
Conclusion
The development of artificial universal blood types is advancing rapidly through enzymatic conversion, bacterial enzyme discovery, antigen masking, and gene editing. These technologies promise to increase the supply of universal donor blood, reduce transfusion risks, and address shortages, especially for rare blood types. As these methods continue to improve, the goal of safe, universally compatible blood transfusions is becoming increasingly achievable 1234+4 MORE.
Sources and full results
Most relevant research papers on this topic